182 related articles for article (PubMed ID: 24817951)
1. Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.
Wu YC; Lv P; Han J; Yu JL; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
Int J Clin Exp Pathol; 2014; 7(4):1553-62. PubMed ID: 24817951
[TBL] [Abstract][Full Text] [Related]
2. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer.
Yu JL; Lv P; Han J; Zhu X; Hong LL; Zhu WY; Wang XB; Wu YC; Li P; Ling ZQ
Arch Pathol Lab Med; 2014 Nov; 138(11):1466-73. PubMed ID: 25357107
[TBL] [Abstract][Full Text] [Related]
3. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer.
Hu XY; Ling ZN; Hong LL; Yu QM; Li P; Ling ZQ
J Clin Lab Anal; 2021 Sep; 35(9):e23936. PubMed ID: 34390026
[TBL] [Abstract][Full Text] [Related]
4. Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer.
Ling ZQ; Lv P; Lu XX; Yu JL; Han J; Ying LS; Zhu X; Zhu WY; Fang XH; Wang S; Wu YC
PLoS One; 2013; 8(6):e67195. PubMed ID: 23826230
[TBL] [Abstract][Full Text] [Related]
5. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
6. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.
Abbaszadegan MR; Moaven O; Sima HR; Ghafarzadegan K; A'rabi A; Forghani MN; Raziee HR; Mashhadinejad A; Jafarzadeh M; Esmaili-Shandiz E; Dadkhah E
World J Gastroenterol; 2008 Apr; 14(13):2055-60. PubMed ID: 18395906
[TBL] [Abstract][Full Text] [Related]
7. Circulating methylated MINT2 promoter DNA is a potential poor prognostic factor in gastric cancer.
Han J; Lv P; Yu JL; Wu YC; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
Dig Dis Sci; 2014 Jun; 59(6):1160-8. PubMed ID: 24385013
[TBL] [Abstract][Full Text] [Related]
8. CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer.
Yu QM; Wang XB; Luo J; Wang S; Fang XH; Yu JL; Ling ZQ
J Surg Oncol; 2012 Nov; 106(6):765-71. PubMed ID: 22514028
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
[TBL] [Abstract][Full Text] [Related]
10. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer.
Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO
Digestion; 2006; 74(2):85-90. PubMed ID: 17139167
[TBL] [Abstract][Full Text] [Related]
11. Detection of p16 promoter hypermethylation in serum of gastric cancer patients.
Kanyama Y; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Cancer Sci; 2003 May; 94(5):418-20. PubMed ID: 12824886
[TBL] [Abstract][Full Text] [Related]
12. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
13. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
14. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.
Hiraki M; Kitajima Y; Sato S; Mitsuno M; Koga Y; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
Ann Surg Oncol; 2010 Apr; 17(4):1177-86. PubMed ID: 19957042
[TBL] [Abstract][Full Text] [Related]
15. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
17. Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.
Wang HL; Zhou PY; Liu P; Zhang Y
Mol Biol Rep; 2014 Jul; 41(7):4481-92. PubMed ID: 24610350
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of whole blood global and specific DNA methylation levels in gastric adenocarcinoma.
Al-Moundhri MS; Al-Nabhani M; Tarantini L; Baccarelli A; Rusiecki JA
PLoS One; 2010 Dec; 5(12):e15585. PubMed ID: 21203466
[TBL] [Abstract][Full Text] [Related]
20. Value of Plasma Methylated SFRP2 in Prognosis of Gastric Cancer.
Yan H; Chen W; Ge K; Mao X; Li X; Liu W; Wu J
Dig Dis Sci; 2021 Nov; 66(11):3854-3861. PubMed ID: 33216241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
